South Korea moves to permit abortion medication for early pregnancies

South Korea has signalled its intention to authorise abortion medication for pregnancies in their earliest stages, a development that reflects evolving attitudes towards reproductive rights in the traditionally conservative nation. The pills would be permitted for use up to nine weeks of gestation, providing an alternative to surgical procedures for women seeking to terminate pregnancies.

The move represents a notable policy shift for South Korea, where abortion laws have historically been among the world's most restrictive. Until recently, the procedure was largely prohibited except in cases of rape, incest, or threats to the mother's health, though enforcement has varied considerably over the years.

Before the medication can reach patients, it must navigate South Korea's regulatory approval process. The country's pharmaceutical authorities will need to assess the drug's safety and efficacy, a process that typically involves clinical review and compliance checks. No timeline for approval has been publicly confirmed.

The decision aligns South Korea with numerous other developed nations that have incorporated medication abortion into their healthcare systems. Medical abortion pills have become increasingly common globally, offering women non-invasive options for early pregnancy termination when administered under appropriate medical supervision.